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Human neuroblastoma cells (SH-SYSY) differentiated by retinoic acid exhibited high threshold-activated N-type Cati currents, which were largely 
inhibited by the two enkephalins, DAGO and DPDPE, as well as by dopamine and somatostatin. The inhibitory effects were fully abolished after 
pretreatment of cells with pertussis toxin. After washing out the toxin, the inhibitory effects re-established with a time constant of about 16 h. The 
recovery of Ca” current inhibition was similar for all tested agonists. Unexpectedly, we observed a neurotransmitter-induced stimulation of Ca” 
currents in approximately 10% of all investigated cells during the recovery phase. Such a stimulatory effect by otherwise inhibitory receptors was 
never seen in control cells. It did also not occur when exogenous purified G-proteins of the G, family were reconstituted via the patch pipette, 
suggesting that additional mechanisms may play a role in the appearance of stimulatory effects during the recovery phase after pertussis toxin 
pretreatment. 
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1. INTRODUCTION 
Voltage-dependent Ca’+ channels play a prominent 
role in the regulation of transmitter secretion [I], while 
Ca2’ channels themselves are under tight control of re- 
ceptors which recognize transmitters and are function- 
ally coupled to channels via G-proteins [2]. One of the 
best studied examples for receptor-dependent modula- 
tion of Ca” channels is the clonal pituitary cell line, 
GH,. Using antisense oligonucleotides as probes to spe- 
cifically suppress the expression of G-proteins, we re- 
cently demonstrated that the inhibitory receptors for 
somatostatin (SST) and acetylcholine (via M4 receptors) 
distinguish between the two splicing variants of u,, as 
well as the j? and y subunits [3,4]. Thyrotropin-releasing 
hormone (TRH), luteinizing hormone-releasing hormone 
and angiotensin II stimulated Ca2+ channels via G,2 
when simultaneous protein kinase C activation oc- 
curred (5,6]. All modulatory effects were abolished by 
pretreatment of cells with pertussis toxin (PTX). This 
exotoxin of Bordetella pertussis ADP-ribosylates the CI 
subunits of G-proteins of the G, and G, families, as well 
as the transducins making them unaccessible for acti- 
vated receptors [7]. In the present study we investigated 
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the recovery of inhibitory modulations after washing 
out PTX. We performed the experiments on human 
neuroblastoma SH-SYSY cells, which are closely re- 
lated to human peripheral sympathetic ganglion cells 
[S]. SH-SYSY cells exhibit receptors, including ,u and 6 
opioid receptors [9,10], as well as receptors for somato- 
statin (SST, receptor subtype not identified) and 
dopamine (DA, presumably receptors of subtype DJ 
which strongly inhibit N-type Ca2’ channels in a PTX- 
sensitive manner [11,12]. Here we report that after pre- 
treatment with PTX at least 90 h were necessary for a 
full recovery of the inhibitory effects on the Ca2+ cur- 
rent. Since the ADP-ribosylation of G-protein a sub- 
units is quasi-irreversible, the reappearance of receptor- 
dependent inhibition is supposed to reflect the rate of 
G-protein resynthesis. Unexpectedly, in about 10% of 
cells investigated uring the recovery phase we observed 
stirn~ato~ effects by otherwise inhibitor agonists. 
2. MATERIALS AND METHODS 
2.1. Culturing of cells 
SH-SYSY cells (clonal human neuroblastoma cells) were grown in 
non-confluent monolayer cultures. Neuronal differentiation was in- 
duced by exposure of cells to retinoic acid (10 pM) for 5 days in 
RPMI-1640 medium (Biochrom, Berlin, Germany) supplemented with 
10% (v/v) fetal calf serum, 2 mM glut~ine, 100 U/ml penicillin and 
100 ,@ml streptomycin in a humified atmosphere with 7% CO2 at 
37OC. The differentiation resulted in a reduction of cell division. 
neurite extension and increase in Ca*’ current [ll]. SH-SYSY cells 
were pretreated for 24 h with 200 @ml PTX. For determinatton of 
the recovery from PTX action, cells were washed twice in PTX-free 
medium and kept in PTX-free RPMI-1640 medium (plus supplements) 
for various times before use for electrophysiological measurements. 
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Fig. 1. Recovery of inhibitory effects after PTX pretreatment of SH-SYSY cells. Shown are superimposed traces of Cal’ currents recorded during 
voltage-clamp ulses from -80 mV to 0 mV under control conditions, after application of DAGO (1 PM), DPDPE (1 PM), DA (30pM) and SST 
(1 ,uM) and after washing-out he agonists. Traces in the first line refer to a control cell, traces in the second line to a cell after PTX pretreatment 
(200 ng/ml for 24 h). Panels 3-7 demonstrate current traces recorded from cells at defined times after washing-out PTX (times are given on the 
left; medium, RPMI-1640 supplemented with 10% fetal calf serum, 2 mM glutamine and penicillin/streptomycin). Stimulatory events are marked 
by frames and arrows. All traces within one horizontal panel were recorded from one cell. The vertical and horizontal calibration bars represent 
50 pA and 50 ms, respectively. 
2.2. Purification of G-proteins 
G-protein cz,-subtypes were purified chromatographically from 
brains (a,, , a,3 or human thrombocytes (a,,, a,,) as described elsewhere 
[13]. In brief, cholate extracts from cell membranes were subsequently 
passed over ion-exchange, gel-filtration and hydrophobic interaction 
columns. Mixtures of isolated a-subunits were then separated by fast 
protein liquid chromatography (FPLC) over Mono Q columns and 
identified by subtype-specific antibodies. The purity of individual G- 
protein cr,-subunits was greater than 95% as determined by silver 
staining of polyacrylamide gels and GTPrS binding. Mixtures of a,,, 
qz and &r were immediately diluted prior to use with pipette solution 
supplemented with Lubrol PX (0.05%) and BSA (0.5%) to a final 
concentration of 40 nM each and infused into SH-SYSY cells. 
2.3. Patch-clamp recordings 
Voltage-sensitive inward currents were recorded using the whole- 
cell patch-clamp technique [14]. The recording patch pipette contained 
(in mM): 110 CsCl,, 1 MgCl,, 3 MgATP, 10 EGTA, 10 CsHEPES (pH 
7.4, adjusted with CsOH). During electrophysiological measurements, 
cells were superfused at 37°C with a solution containing (in mM): 125 
NaCl, 10.8 BaCl,, 1 MgCl,, 5.4 CsCl,, 10 glucose, 10 NaHEPES @H 
7.4, adjusted with NaOH). Ba” was used as the charge carrier in order 
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to increase currents through Ca*’ channels and to block K’ currents. 
Ba’+ currents through Ca” channels were recorded under voltage- 
clamp conditions during 100 ms long pulses from -80 mV to 0 mV. 
Altogether 121 cells were investigated. 
3. RESULTS AND DISCUSSION 
SH-SYSY cells differentiated for 5 days with retinoic 
acid exhibited Ba2+ currents through voltage-dependent 
CaZ’ channels of 25.3 & 7.03 pA/pF amplitude when 
voltage-clamped from -80 mV to 0 mV. The inward 
currents were fully blocked by w-conotoxin (1 PM) but 
only slightly affected by the L-type Ca2+ channel 
blocker and opener, PN200-110 (1 PM) and BayK8644 
(1 FM), respectively, suggesting that SH-SYSY cells 
preferentially express high-threshold N-type Ca2’ chan- 
nels. Superfusion of cells with the @-opioid agonist, 
DAGO (1 FM), the &opioid agonist, DPDPE (1 PM), 
as well as with DA (30 PM) and SST (1 PM), caused a 
strong inhibition of the Ca” current (Fig. 1). The mean 
inhibition (+ S.E.M.) amounted to 77.6 + 2.5% 
(n = IO), 63.9 f 2.0% (n = 12), 59.9 f 2.0% (n = 9) and 
63.7 ? 3.8% (n = 10) for DAGO, DPDPE, DA and 
SST, respectively. All inhibitory effects occurred within 
seconds and were fully reversible on washing-out the 
agonists. The effects of DAGO and DPDPE were an- 
tagonized by naloxone (10 PM). In addition to the inhi- 
bition, the neurotransmitters induced an apparent slow- 
ing of the time-course of activation, presumably due to 
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Fig. 2. Time-course of recovery of Ca*’ current modulation after PTX 
pretreatment. (A) The recovery of inhibition is given with reference 
to the mean inhibition measured in control SH-SYSY cells. The differ- 
ent symbols represent different agonists: DAGO (o), DPDPE (o), DA 
(o), SST (v). The data were fitted according tof(t) =fm, - exp(-t/z), 
with z = 16.6 h and_&_, = 0.9. (B) Stimulatory events are shown as 
percentage increase of the control current. The same symbols as in A 
are used. 
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Fig. 3. Blockade of opioid-induced stimulation of Ca” current by 
naloxone. The current traces were recorded during voltage-clamp 
pulses from -80 mV to 0 mV. Con refers to control traces, DAGO to 
the traces recorded under superfusion with DAGO, DAGO + NX to 
traces after superfusion of DAGO plus naloxone and wo to traces after 
washing-out he agonist. While DAGO caused the stimulation in A. 
it had no effect if naloxone was superfused in addition (B, same cell 
as in A). The vertical and horizontal calibration bars represent 50 pA 
and 50 ms, respectively. 
a voltage-dependent unblocking of G-proteins [ 151. Pre- 
treatment of SH-SYSY cells with 200 q/ml PTX for 24 
h resulted in the abolishion of the effects of DAGO, 
DPDPE, DA and SST (Fig. 1). 
To functionally determine the rate of synthesis of 
G-proteins, we used the fact that PTX irreversibly 
ADP-ribosylates G-proteins [16]. PTX-pretreated SH- 
SYSY cells were re-incubated for variable times in PTX- 
free medium (plus supplements) before measuring the 
effects of DAGO, DPDPE, DA and SST. The re-estab- 
lishment of modulation was assumed to represent he 
recovery of G-proteins in the signal transduction proc- 
ess. The measured inhibitory neurotransmitter effects 
were referred to the mean effects observed by the respec- 
tive agonists in control experiments (Fig. 2). The phase 
of re-appearance of inhibitory effects could be roughly 
described by a monoexponential process with a time 
constant of approximately 16 h. After 90 h, the effects 
were fully restored for all the agonists tested. These 
times are in the range of values reported previously. By 
determining the degradation rate of radioactively la- 
beled G-proteins, Silbert et al. [I 71 suggested a turnover 
rate for G, of about 60 h in GH, and more than 140 h 
in rat cardiomyocytes. Similar times were also observed 
after injection of antisense oligonucleotides uppressing 
different G-protein subunits [3]. During the phase of 
recovery the slowing of activation was less pronounced 
compared to control cells. Within a given cell the inhib- 
itory effects varied considerably from agonist to ag- 
onist, suggesting a different efficiency of G-protein re- 
synthesis for the different receptors. 
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Fig. 4. Reconstitution of G, into PTX-pretreated SH-SYSY cells. Shown are superimposed traces of Ca” currents recorded under the same 
conditions as given in the legend to Fig. 1. Traces in the first line refer to a control cell, traces in the second line to a cell after PTX pretreatment 
and traces in the third line to a PTX-treated cell after infusion of a mixture of a,,, cq2 and cx,, (40 nM each). The vertical and horizontal calibration 
bars represent 50 pA and 50 ms, respectively. 
Unexpectedly, about 10% of all cells tested (n = 121) 
responded to the inhibitory agonists (same concentra- 
tions) with stimulations of the Ca*’ channel current. 
These stimulatory events occurred during the first 60 h 
of recovery (see Fig. 2B) and, for a given cell, was not 
seen simultaneously for all agonists (see Fig. I, panels 
5 and 6). No preference for a certain agonist could be 
detected. The stimulations ranged from 20% to 90% of 
controls (n = 13). Similar to the inhibitory effects, the 
stimulations occurred fast and were fully reversible on 
washing-out he agonists. The stimulatory effects were 
obviously mediated by receptors since they could be 
antagonized by the respective receptor antagonists. In 
the case of stimulations of Ca*’ channel currents by 
DAGO, naloxone (10 PM) completely abolished the 
effect in the same cell (Fig. 3). So far, a G-protein- 
dependent stimulation has only been described for en- 
docrine cells where it is mediated by G,2 [5,6,18] and for 
cardiac and skeletal muscle where it is mediated by Gs 
[19]. Typically, these responses are induced by agonists 
inducing a PI response (e.g. TRH, angiotensin 11) or 
stimulating adenylyl cyclase (e.g. p-adrenergic agonists) 
but never by inhibitory agonists such as opioids, DA 
and SST. It may be speculated that during the process 
of re-synthesis, ‘wrong G-proteins’ reconstitute which 
would then mediate the inverse modulatory effect. Since 
by using the [c+~‘P]GTP azidoanilide-labelling method 
opioid agonists and SST have been demonstrated to 
activate both G, and G,, in a neuronal cell line [20], it 
is plausible that Gi2 recovers faster than G,, resulting in 
a preferential coupling of the inhibitory receptors to G,*, 
leading to the observed stimulator-y effects. To test this 
hypothesis, we directly reconstituted a mixture of puri- 
fied a,,, a,* and aI3 via the patch-pipette into SH-SYSY 
cells (Fig. 4). However, the exogenous G-proteins never 
resulted in stimulator-y responses by DAGO, DPDPE 
or SST. Therefore additional mechanisms may play a 
role in the appearance of stimulatory effects during the 
recovery phase after PTX pretreatment. A possible 
pathway for activation of protein kinase C, which was 
found to be essential for the TRH-dependent stimula- 
tion of the Ca*’ current in GH, cells [6], may be due to 
serum factors. 
The stimulatory effects seen during the re-synthesis 
phase after washing out PTX demonstrate a high varia- 
bility of receptor-effecter coupling on the level of G- 
proteins [21], which may play a physiological role in the 
modulation of synaptic activity during differentiation 
or slowly developing adaptation processes. In addition 
to the well-known modulatory events regulating volt- 
age-operated Ca” channels [22,23], they may contribute 
to the plasticity of synaptic transmission. 
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